214 related articles for article (PubMed ID: 25605045)
1. Does combined clinical and ultrasound assessment allow selection of individuals with rheumatoid arthritis for sustained reduction of anti-tumor necrosis factor therapy?
Marks JL; Holroyd CR; Dimitrov BD; Armstrong RD; Calogeras A; Cooper C; Davidson BK; Dennison EM; Harvey NC; Edwards CJ
Arthritis Care Res (Hoboken); 2015 May; 67(6):746-53. PubMed ID: 25605045
[TBL] [Abstract][Full Text] [Related]
2. Power Doppler ultrasonographic monitoring of response to anti-tumor necrosis factor therapy in patients with rheumatoid arthritis.
Naredo E; Möller I; Cruz A; Carmona L; Garrido J
Arthritis Rheum; 2008 Aug; 58(8):2248-56. PubMed ID: 18668537
[TBL] [Abstract][Full Text] [Related]
3. Synovial features of patients with rheumatoid arthritis and psoriatic arthritis in clinical and ultrasound remission differ under anti-TNF therapy: a clue to interpret different chances of relapse after clinical remission?
Alivernini S; Tolusso B; Petricca L; Bui L; Di Sante G; Peluso G; Benvenuto R; Fedele AL; Federico F; Ferraccioli G; Gremese E
Ann Rheum Dis; 2017 Jul; 76(7):1228-1236. PubMed ID: 28119289
[TBL] [Abstract][Full Text] [Related]
4. Prediction of relapse after discontinuation of biologic agents by ultrasonographic assessment in patients with rheumatoid arthritis in clinical remission: high predictive values of total gray-scale and power Doppler scores that represent residual synovial inflammation before discontinuation.
Iwamoto T; Ikeda K; Hosokawa J; Yamagata M; Tanaka S; Norimoto A; Sanayama Y; Nakagomi D; Takahashi K; Hirose K; Sugiyama T; Sueishi M; Nakajima H
Arthritis Care Res (Hoboken); 2014 Oct; 66(10):1576-81. PubMed ID: 24515410
[TBL] [Abstract][Full Text] [Related]
5. Power Doppler ultrasound monitoring of response to anti-tumour necrosis factor alpha treatment in patients with rheumatoid arthritis.
Iagnocco A; Finucci A; Ceccarelli F; Perricone C; Iorgoveanu V; Valesini G
Rheumatology (Oxford); 2015 Oct; 54(10):1890-6. PubMed ID: 26070937
[TBL] [Abstract][Full Text] [Related]
6. Presence of power Doppler synovitis in rheumatoid arthritis patients with synthetic and/or biological disease-modifying anti-rheumatic drug-induced clinical remission: experience from a Chinese cohort.
Geng Y; Han J; Deng X; Zhang Z
Clin Rheumatol; 2014 Aug; 33(8):1061-6. PubMed ID: 24777468
[TBL] [Abstract][Full Text] [Related]
7. Semi-quantitative analysis of rheumatoid finger joint synovitis using power Doppler ultrasonography: when to perform follow-up study after treatment consisting mainly of antitumor necrosis factor alpha agent.
Kamishima T; Sagawa A; Tanimura K; Shimizu M; Matsuhashi M; Shinohara M; Hagiwara H; Henmi M; Narita A; Terae S; Shirato H
Skeletal Radiol; 2010 May; 39(5):457-65. PubMed ID: 19936743
[TBL] [Abstract][Full Text] [Related]
8. Ultrasound-detected activity in rheumatoid arthritis on methotrexate therapy: Which joints and tendons should be assessed to predict unstable remission?
Janta I; Valor L; De la Torre I; Martínez-Estupiñán L; Nieto JC; Ovalles-Bonilla JG; Martínez-Barrio J; Bello N; Hinojosa M; Montoro M; González CM; López-Longo J; Monteagudo I; Carreño L; Naredo E
Rheumatol Int; 2016 Mar; 36(3):387-96. PubMed ID: 26712373
[TBL] [Abstract][Full Text] [Related]
9. Musculoskeletal ultrasound as a biomarker of remission - results from a one-year prospective study in patients with rheumatoid arthritis.
Sapundzhieva T; Karalilova R; Batalov A
Med Ultrason; 2018 Dec; 20(4):453-460. PubMed ID: 30534652
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of abatacept tapering therapy for sustained remission in patients with rheumatoid arthritis: Prospective single-center study.
Yoshida S; Kotani T; Kimura Y; Matsumura Y; Yoshikawa A; Tokai N; Ozaki T; Nagai K; Takeuchi T; Makino S; Arawaka S
Int J Rheum Dis; 2019 Jan; 22(1):81-89. PubMed ID: 30168272
[TBL] [Abstract][Full Text] [Related]
11. Subclinical synovitis measured by ultrasound in rheumatoid arthritis patients with clinical remission induced by synthetic and biological modifying disease drugs.
Cruces M; Al Snih S; Serra-Bonett N; Rivas JC
Reumatol Clin (Engl Ed); 2019; 15(4):218-222. PubMed ID: 29032909
[TBL] [Abstract][Full Text] [Related]
12. Calprotectin and TNF trough serum levels identify power Doppler ultrasound synovitis in rheumatoid arthritis and psoriatic arthritis patients in remission or with low disease activity.
Inciarte-Mundo J; Ramirez J; Hernández MV; Ruiz-Esquide V; Cuervo A; Cabrera-Villalba SR; Pascal M; Yagüe J; Cañete JD; Sanmarti R
Arthritis Res Ther; 2016 Jul; 18(1):160. PubMed ID: 27391315
[TBL] [Abstract][Full Text] [Related]
13. Predicting Imaging Remission in Rheumatoid Arthritis: a Case-control Ultrasound Study.
Chung SW; Choi JY; Lee SH; Song R; Yang HI; Hong SJ; Lee YA
J Korean Med Sci; 2020 Aug; 35(31):e260. PubMed ID: 32776721
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal power Doppler ultrasonographic assessment of joint inflammatory activity in early rheumatoid arthritis: predictive value in disease activity and radiologic progression.
Naredo E; Collado P; Cruz A; Palop MJ; Cabero F; Richi P; Carmona L; Crespo M
Arthritis Rheum; 2007 Feb; 57(1):116-24. PubMed ID: 17266071
[TBL] [Abstract][Full Text] [Related]
15. Relation of Doppler ultrasound synovitis versus clinical synovitis with changes in native complement component levels in rheumatoid arthritis patients treated with biologic disease-modifying anti-rheumatic drugs.
Montoro Alvarez M; Chong OY; Janta I; González C; López-Longo J; Monteagudo I; Valor L; Garrido J; Lau IS; Rosman A; Naredo E; Carreño L
Clin Exp Rheumatol; 2015; 33(2):141-5. PubMed ID: 25665178
[TBL] [Abstract][Full Text] [Related]
16. Disease remission state in patients treated with the combination of tumor necrosis factor blockade and methotrexate or with disease-modifying antirheumatic drugs: A clinical and imaging comparative study.
Saleem B; Brown AK; Keen H; Nizam S; Freeston J; Karim Z; Quinn M; Wakefield R; Hensor E; Conaghan PG; Emery P
Arthritis Rheum; 2009 Jul; 60(7):1915-22. PubMed ID: 19565512
[TBL] [Abstract][Full Text] [Related]
17. Factors influencing concordance between clinical and ultrasound findings in rheumatoid arthritis.
Le Boedec M; Jousse-Joulin S; Ferlet JF; Marhadour T; Chales G; Grange L; Hacquard-Bouder C; Loeuille D; Sellam J; Albert JD; Bentin J; Chary-Valckenaere I; D'Agostino MA; Etchepare F; Gaudin P; Hudry C; Dougados M; Saraux A
J Rheumatol; 2013 Mar; 40(3):244-52. PubMed ID: 23322464
[TBL] [Abstract][Full Text] [Related]
18. Using a DAS28-CRP-steered treat-to-target strategy does not eliminate subclinical inflammation as assessed by ultrasonography in rheumatoid arthritis patients in longstanding clinical remission.
Terslev L; Brahe CH; Østergaard M; Fana V; Ammitzbøll-Danielsen M; Møller T; Krabbe S; Hetland ML; Døhn UM
Arthritis Res Ther; 2021 Feb; 23(1):48. PubMed ID: 33522948
[TBL] [Abstract][Full Text] [Related]
19. Ultrasound-detected joint inflammation and B cell count: related variables for rituximab-treated RA patients?
Valor L; Martínez-Estupiñán L; Janta I; Nieto JC; Ovalles-Bonilla JG; González-Fernández C; Del Rio T; Hernández-Flórez D; Monteagudo I; López-Longo FJ; Naredo E
Rheumatol Int; 2016 Jun; 36(6):793-7. PubMed ID: 27072348
[TBL] [Abstract][Full Text] [Related]
20. The effect of deep or sustained remission on maintenance of remission after dose reduction or withdrawal of etanercept in patients with rheumatoid arthritis.
Tanaka Y; Smolen JS; Jones H; Szumski A; Marshall L; Emery P
Arthritis Res Ther; 2019 Jul; 21(1):164. PubMed ID: 31277720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
